Ziff Davis' General Counsel Sale Signals Investor Impact
A senior executive at Ziff Davis sold a sizable block of shares. This article dives into what that move could mean fo...
When Should I Start Thinking About Retirement
Understanding when to start thinking about retirement can make a big difference. Explore key factors to help you plan effectively.
24,441 articlesWith Interest Rate Cut: Should You Sell SoFi Stock Now?
As the Fed weighs its next move, SoFi stock sits at a crossroads. This guide explains how to think through your optio...
NVIDIA Stock Down Over Last Month: What It Means Now
NVIDIA stock has fallen over the past month, triggering worries about headlines and momentum. This article breaks dow...
Occidental Petroleum Capital Spending: 2026 Outlook
As crude prices rise, Occidental Petroleum trims its 2026 capital spending. This deep dive explains what the move mea...
Alkami Stock Down 50% Signals Turnaround Confidence
Even as alkami stock down 50% frames a challenging chapter, a new large stake in Alkami Technology points to a differ...
StubHub Stock Just Crashed: What Investors Should Do Next
A disappointing earnings quarter sent stubhub stock just crashed. This guide breaks down the reasons, what it signals...
Things Landlords Responsible When Renting to Tenants
Renting property comes with big responsibilities. This article breaks down the four essential duties landlords must m...
Tiny Biotech Just Beat AbbVie's Drug: Risk for Investors?
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Abercrombie Stock Rebounded Today: What Moved the Stock Higher
Abercrombie & Fitch shares surged after a stronger-than-expected quarter. This article breaks down the factors behind...
Spacex Date: What Investors Need Before the SPCX IPO
SpaceX is eyeing a historic IPO. This guide explains the spacex date: what investors should watch, how pricing could ...
AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Vertex Paying 102% Premium: Is the Crinetics Deal Worth It?
Vertex is pursuing Crinetics with a substantial all-cash offer. This deep dive breaks down what the $10 billion bid m...
Popular Topics
Fable
Smart Money Moves For Everyday Life
Investment Strategies In Energy Sector
Best Index Funds For Retirement
Investment Strategies
Untitled D6eff7ea
Crypto For Beginners
Best Dividend Etfs
Index
Innovative Skincare Clinical
Dutch Salary
Blue Owl
Budget
Ai Healthcare News
Penalty Vs No Penalty Depending On Lock Status